Designed for qualitative detection of SARS-CoV-2 antibodies in human serum, plasma, and whole blood samples, novel coronavirus antibody detection reagent (Colloidal Gold Method) is regarded as auxiliary detection metrics towards on-site screening for suspected cases that have the negative results after nucleic acid testing. This rapid test can aid in the diagnosis of coronavirus infection and significantly shorten the detection time, yielding the results in 15 minutes.
We have testing kits for Covid-19 In inventory now for immediate shipping. High sensitivity rapid test kits for Covid-19. 250K available now for USA and international shipping, Inventory moving fast.
Covi-G (powered by Cipla) Rapid Test kit combines quality, efficacy and convenience - offering precise results in 10-15 mins
Features & Benefits
Covid IgM-IgG Serologic Rapid Test for COVID-19 is used to qualitatively detect IgG and IgM antibodies against SARS-CoV-2 in whole blood in vitro
Precise and effective
- Tests for both IgM and IgG antibodies
- Sensitivity and specificity comparable to highest available offerings Sensitivity: IgG 92%, IgM 82%; Specificity IgG 97%, IgM 94%
- ->92% total accuracy: IgG 96,5% - IgM: 92,8%
- High reproducibility (consistent results across the same patient)
-
High quality, reliable & convenient
- Single-prick blood test
- 10-15 minutes per test
- Intuitive visual interpretation
- No specialized training or equipment needed
- Portable hence highly scalable
- Storage at room temperature (2-30 C)
- Conformance to CE (Europe) and ISO manufacturing
The Covi-G platform for Rapid Antibody tests has a set of unique and unparalleled offerings
SUSTAINABLE QUALITY
Validated Declaration of CE conformity
- Launched in Feb 2020, among the earliest technologies/ kits to declare CE-compliance, and continuing strong compared to competitors
- Under process for receiving USDA E authorization
Among only 3 integrated vendors of Rapid tests Developed and manufactured in Europe (Belgium)
- One of the very lew players manufacturing in Europe, with zero complaints also certified locations
ACCEPTABILITY ACROSS MARKETS
Demonstrated capabilities in local countries validation
- Independent local studies conducted in Belgium and France, validating the sensitivity and specificity of the product
Participated in published research
- Covl-G kit compared lavorably with 7 lgFL IgM rapid antibody tests and IgG ELISA in a comparative study published by Elsevier Science Direct, verifying sensitivity of the kit
PROVEN COMMERCIAL EXPERIENCE
Sold in 25+ countries already
- Including Europe, US, Canada, Africa and multiple developed and emerging markets
- Under participation in govt tenders
Robust manufacturing capability and capacity
- ISO-certified manufacturing site
- Ability to cater to high manufacturing volumes from Belgium, to ensure adequale QA and commercial viability
AFFORDABLE AND SCALABLE
Viable to scale up at Institutions and Retail level
- Economical cost per-unit established over many months of process improvement and local manufacturing
- Can cater to insured as well as out-of pocket populations
Continuous improvement through R&D
- Multiple rounds of performance testing complete, further testing in 5 reputed hospitals underway in Belgium, France, USA and Canada
- Other platforms including Rapid antigen testing also being developed
A world of excellence in in vitro diagnostics produces and market
immunochemistry (elisa/eia clia/lia), urine reagent test strips, fertility's, serology, infectious disease rt, clia waived tests, drug screening, blood banking, clinical chemistry reagents, research chemistries, coagulation, dr.g glucometer, genotype molecular diagnostics assays , immunofluorescence assays, microbiology , covid 19 antigen /antibody rapid tests/elisa assays and pcr test kits, veterinary test kits, biodefense test kits and technology transfer..
